121 related articles for article (PubMed ID: 12702763)
1. Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein.
Root MJ; Hamer DH
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5016-21. PubMed ID: 12702763
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
[TBL] [Abstract][Full Text] [Related]
3. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
4. Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.
Teixeira C; Gomes JR; Gomes P; Maurel F; Barbault F
Eur J Med Chem; 2011 Apr; 46(4):979-92. PubMed ID: 21345545
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.
Pan C; Liu S; Jiang S
J Formos Med Assoc; 2010 Feb; 109(2):94-105. PubMed ID: 20206833
[TBL] [Abstract][Full Text] [Related]
6. CD4 activation of HIV fusion.
Sattentau QJ
Int J Cell Cloning; 1992 Nov; 10(6):323-32. PubMed ID: 1281202
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss CD
AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
[TBL] [Abstract][Full Text] [Related]
9. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
[TBL] [Abstract][Full Text] [Related]
10. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
11. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
Liu S; Lu H; Zhao Q; He Y; Niu J; Debnath AK; Wu S; Jiang S
Biochim Biophys Acta; 2005 May; 1723(1-3):270-81. PubMed ID: 15823507
[TBL] [Abstract][Full Text] [Related]
12. Membrane-Active Sequences within gp41 Membrane Proximal External Region (MPER) Modulate MPER-Containing Peptidyl Fusion Inhibitor Activity and the Biosynthesis of HIV-1 Structural Proteins.
Zhang SM; Jejcic A; Tam JP; Vahlne A
PLoS One; 2015; 10(7):e0134851. PubMed ID: 26230322
[TBL] [Abstract][Full Text] [Related]
13. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
[TBL] [Abstract][Full Text] [Related]
14. Protein design of an HIV-1 entry inhibitor.
Root MJ; Kay MS; Kim PS
Science; 2001 Feb; 291(5505):884-8. PubMed ID: 11229405
[TBL] [Abstract][Full Text] [Related]
15. Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.
Frey G; Rits-Volloch S; Zhang XQ; Schooley RT; Chen B; Harrison SC
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13938-43. PubMed ID: 16963566
[TBL] [Abstract][Full Text] [Related]
16. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
Day JR; Van Damme N; Guatelli JC
Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
[TBL] [Abstract][Full Text] [Related]
17. Virus entry as a target for anti-HIV intervention.
Esté JA
Curr Med Chem; 2003 Sep; 10(17):1617-32. PubMed ID: 12871111
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding.
Kahle KM; Steger HK; Root MJ
PLoS Pathog; 2009 Nov; 5(11):e1000674. PubMed ID: 19956769
[TBL] [Abstract][Full Text] [Related]
19. Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein.
Baldwin CE; Berkhout B
Retrovirology; 2006 Nov; 3():84. PubMed ID: 17134507
[TBL] [Abstract][Full Text] [Related]
20. A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
Wensel D; Sun Y; Davis J; Li Z; Zhang S; McDonagh T; Fabrizio D; Cockett M; Krystal M
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
